We are live on
!
Find out more
BCM
Boone Capital Management Portfolio holdings
AUM
$326M
1-Year Est. Return
86.31%
This Fund
S&P 500
This Quarter
Est. Return
-3.41%
1 Year Est. Return
+86.31%
3 Year Est. Return
+255.12%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$233M
AUM Growth
-$60.6M
(-21%)
Cap. Flow
-$57.5M
Cap. Flow
% of AUM
-24.65%
Top 10 Holdings %
Top 10 Hldgs %
96.94%
Holding
17
New
5
Increased
3
Reduced
3
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Avantor
AVTR
|
+$23.2M |
| 2 |
UnitedHealth
UNH
|
+$22.2M |
| 3 |
Neurocrine Biosciences
NBIX
|
+$20.7M |
| 4 |
Icon
ICLR
|
+$13.6M |
| 5 |
Abeona Therapeutics
ABEO
|
+$7.14M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Unum
UNM
|
+$33.1M |
| 2 |
Globus Medical
GMED
|
+$26.4M |
| 3 |
Molina Healthcare
MOH
|
+$22.3M |
| 4 |
Perrigo
PRGO
|
+$19.8M |
| 5 |
Intuitive Surgical
ISRG
|
+$19.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 90.24% |
| 2 | Financials | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Medtronic
MDT
$109B
| $37.4M | 16.03% |
428,789
+35,052
| +9% | +$2.97M |
|
2
Mirum Pharmaceuticals
MIRM
$6.63B
| $32.6M | 14% |
641,448
+38,130
| +6% | +$1.7M |
|
3
BioMarin Pharmaceuticals
BMRN
$11.5B
| $24.6M | 10.55% |
447,449
+120,170
| +37% | +$7.08M |
|
|
4
Avantor
AVTR
$9.28B
| $22.8M | 9.78% |
+1,694,482
| New | +$23.2M |
|
|
5
Unum
UNM
$13.6B
| $22.8M | 9.76% |
281,790
-418,810
| -60% | -$33.1M |
|
|
6
Neurocrine Biosciences
NBIX
$16.8B
| $22.7M | 9.72% |
+180,338
| New | +$20.7M |
|
7
Pennant Group
PNTG
$1.41B
| $19.4M | 8.31% |
649,022
-70,115
| -10% | -$1.92M |
|
|
8
UnitedHealth
UNH
$381B
| $18.1M | 7.77% |
+58,112
| New | +$22.2M |
|
|
9
Icon
ICLR
$12.7B
| $13.9M | 5.98% |
+95,832
| New | +$13.6M |
|
10
Cigna
CI
$74.7B
| $11.8M | 5.05% |
35,600
-35,259
| -50% | -$11.4M |
|
|
11
Abeona Therapeutics
ABEO
$361M
| $7.13M | 3.06% |
+1,254,658
| New | +$7.14M |
|
12
Biohaven
BHVN
$2.03B
| – | – |
-270,198
| Closed | -$6.5M |
|
|
13
Globus Medical
GMED
$10.7B
| – | – |
-360,764
| Closed | -$26.4M |
|
|
14
Intuitive Surgical
ISRG
$127B
| – | – |
-38,930
| Closed | -$19.3M |
|
|
15
Molina Healthcare
MOH
$10.2B
| – | – |
-67,555
| Closed | -$22.3M |
|
16
Orthofix Medical
OFIX
$473M
| – | – |
-948,202
| Closed | -$15.5M |
|
|
17
Perrigo
PRGO
$1.41B
| – | – |
-704,824
| Closed | -$19.8M |
|
Similar funds
ISFAN
JHWEPV
AFA
ECH
DCM
MVM
CCG
TC
Boone Capital Management's Q2 2025 Portfolio in Review
As of Q2 2025, Boone Capital Management held 17 positions worth $233M, down 21% from $294M the previous quarter. Its ten largest holdings account for 97% of the portfolio.
Boone Capital Management withdrew a net $57.5M in Q2 2025, closing 6 positions and reducing 3 holdings. Its most notable exit was Globus Medical, an estimated $26.4M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 90% of assets, up from 81% a quarter earlier, followed by Financials.
Against the trend, Boone Capital Management opened a new position in Avantor worth $22.8M.
- Boone Capital Management's largest Q2 2025 buy was Avantor: 1,694,482 shares worth $22.8M.
- Boone Capital Management added most to BioMarin Pharmaceuticals in Q2 2025, an estimated $7.08M increase.
- Boone Capital Management's biggest Q2 2025 reduction was Unum, cutting an estimated $33.1M.
- Boone Capital Management fully exited Globus Medical in Q2 2025, selling an estimated $26.4M.
- Boone Capital Management's ten largest holdings make up 97% of its $233M portfolio in Q2 2025.
- Boone Capital Management opened 5 new positions and closed 6 in Q2 2025.
- Boone Capital Management's portfolio value fell 21% quarter-over-quarter to $233M.
Based on Boone Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.